The Impact of Insulin Degludec on Glucocorticoid-Induced Hyperglycemia in Patients with Diabetes and COVID-19 Infection
Abstract Objective: The objective was to assess the effectiveness and safety of insulin degludec (IDeg) on glycemic control in people with diabetes (PWD) hospitalized for moderate-to-severe coronavirus disease 2019 (COVID-19). Design: This study is a retrospective cohort study. Setting and Participa...
Saved in:
Main Authors: | Varun Prasanna, Ravindranath Venketesan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-04-01
|
Series: | Journal of Diabetology |
Subjects: | |
Online Access: | https://doi.org/10.4103/jod.jod_40_23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insulin degludec 100 U/mL for treatment of spontaneous diabetes mellitus in dogs
by: Jocelyn Mott, et al.
Published: (2025-01-01) -
Systemically modeling the dynamics of plasma insulin insubcutaneous injection of insulin analogues for type 1 diabetes
by: Jiaxu Li, et al.
Published: (2008-11-01) -
Hypoglychemic activity of Moringa oleifera extract in streptozotocin-induced diabetic rats
by: Rabiatul Adawiyah, et al.
Published: (2024-08-01) -
Physiological and pathophysiological actions of insulin in the liver
by: Naoto Kubota, et al.
Published: (2025-02-01) -
Neuroimmune axis: Linking environmental factors to pancreatic β-cell dysfunction in Diabetes
by: Luz Andreone
Published: (2025-02-01)